Stage III Bladder Urothelial Carcinoma AJCC v6 and v7
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11714 | Durvalumab | 0 | Active Not Recruiting | 1 |
| DB11771 | Tremelimumab | 0 | Active Not Recruiting | 1 |
| DB08871 | Eribulin | 1 / 2 | Active Not Recruiting | 1 |
| DB08871 | Eribulin | 2 | Completed | 1 |
| DB00441 | Gemcitabine | 2 | Completed | 1 |
| DB09035 | Nivolumab | 2 | Completed | 1 |
| DB09037 | Pembrolizumab | 2 | Withdrawn | 1 |
| DB11836 | Sapanisertib | 2 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 3 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 3 | Active Not Recruiting | 1 |
| DB14851 | Relatlimab | 3 | Recruiting | 1 |